Attach to Form 990 or Form 990-EZ.
See separate instructions.| (i) Name of supported organization |
(ii) EIN |
(iii) Type of organization (described on lines 1- 9 above or IRC section (see instructions)) |
(iv) Is the organization in col. (i) listed in your governing document? |
(v) Did you notify the organization in col. (i) of your support? |
(vi) Is the organization in col. (i) organized in the U.S.? |
(vii) Amount of support? |
|||
|---|---|---|---|---|---|---|---|---|---|
| Yes | No | Yes | No | Yes | No | ||||
| Total | |||||||||
| Calendar year(or fiscal year beginning in) | (a) 2007 | (b) 2008 | (c) 2009 | (d) 2010 | (e) 2011 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") .... | 132,775,607 | 127,995,868 | 134,999,587 | 174,658,160 | 159,779,664 | 730,208,886 |
| 2 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf....... | 0 | 0 | 0 | 0 | 0 | 0 |
| 3 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | 0 | 0 | 0 | 0 | 0 | 0 |
| 4 | Total. Add lines 1 through 3.. | 132,775,607 | 127,995,868 | 134,999,587 | 174,658,160 | 159,779,664 | 730,208,886 |
| 5 | The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f).. | 1,749,349 | |||||
| 6 | Public Support. Subtract line 5 from line 4. | 728,459,537 | |||||
| Calendar year(or fiscal year beginning in) | (a) 2007 | (b) 2008 | (c) 2009 | (d) 2010 | (e) 2011 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 7 | Amounts from line 4.. | 132,775,607 | 127,995,868 | 134,999,587 | 174,658,160 | 159,779,664 | 730,208,886 |
| 8 | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources.. | 8,682,291 | 6,957,976 | 3,548,746 | 3,812,083 | 4,528,150 | 27,529,246 |
| 9 | Net income from unrelated business activities, whether or not the business is regularly carried on.. | 0 | 0 | 0 | 0 | 0 | 0 |
| 10 | Other income. (Explain in Part IV.) Do not include gain or loss from the sale of capital assets.. | 81,914 | 71,369 | 2,589,864 | 84,038 | 378,313 | 3,205,498 |
| 11 | Total support (Add lines 7 through 10). | 760,943,630 | |||||






| Calendar year(or fiscal year beginning in) | (a) 2007 | (b) 2008 | (c) 2009 | (d) 2010 | (e) 2011 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") . | ||||||
| 2 | Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose...... | ||||||
| 3 | Gross receipts from activities that are not an unrelated trade or business under section 513.. | ||||||
| 4 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf... | ||||||
| 5 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | ||||||
| 6 | Total. Add lines 1 through 5. | ||||||
| 7a | Amounts included on lines 1, 2, and 3 received from disqualified persons... | ||||||
| b | Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year. | ||||||
| c | Add lines 7a and 7b.. | ||||||
| 8 | Public Support (Subtract line 7c from line 6.) | ||||||
| Calendar year (or fiscal year beginning in) | (a) 2007 | (b) 2008 | (c) 2009 | (d) 2010 | (e) 2011 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 9 | Amounts from line 6... | ||||||
| 10a | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources.. | ||||||
| b | Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975. | ||||||
| c | Add lines 10a and 10b. | ||||||
| 11 | Net income from unrelated business activities not included in line 10b, whether or not the business is regularly carried on. | ||||||
| 12 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part IV.) | ||||||
| 13 | Total support (Add lines 9, 10c, 11 and 12.). | ||||||




| Facts And Circumstances Test |
|---|
| Explanation |
|---|
| Software ID: | |
| Software Version: |
Attach to Form 990 or 990-EZ.| Identifier | Return Reference | Explanation |
|---|---|---|
| Volunteers | Form 990, Part I, Question 6 | Volunteers serve in a variety of ways but the greatest number of volunteers assist with the Breast Cancer 3 Day series. |
| Program Service Accomplishments | Part III | Nancy G. Brinker promised her dying sister, Susan G. Komen, that she would do everything in her power to end breast cancer forever. In 1982, that promise became Susan G. Komen for the Cure (Komen) and launched the global breast cancer movement. Today, Susan G. Komen for the Cure is the world's largest grassroots network of breast cancer survivors and activists fighting to save lives, empower people, ensure quality care for all and energize science to find the cures. Thanks to events like the Race for the Cure, Komen and its Affiliates have invested $2.2 billion to fulfill its promise, becoming the largest source of nonprofit funds dedicated to the fight against breast cancer in the world. A - Research and Training Komen has contributed to major advances in breast cancer research over the past 30 years. Komen's Research Programs are designed to advance the translation of research discoveries into new ways to diagnose, treat, and prevent breast cancer, leading to a reduction of breast cancer incidence and mortality within the next decade. To ensure maximum impact for its research dollars, Komen is guided by a Scientific Advisory Board, a group of internationally recognized doctors, scientists and advocates, and consults with the Komen Scholars, a group comprised of 68 scientists and advocates. Komen awards grants to individual scientists, research teams, and organizations around the world through competitive, review processes that ensure maximum impact for our research dollars. In fiscal year 2012, Komen made 144 grants through its Research and Training Grants Program to support research and training in the United States and other countries, including Australia, Belgium, and Canada. The following Request for Applications (RFA) driven grant opportunities were offered by Komen during fiscal year 2012: -Promise Grants: Large-scale grants, up to $4.2 million each, during a three-year period, targeted to research that seeks to understand and prevent late recurrence of breast cancer. -Post-Doctoral Fellowships: Grants of $60,000 per year for two or three years, to attract, train, and retain promising young researchers into the field of breast cancer research. -Career Catalyst Research: Grants of $150,000 per year for two to three years, to fill a critical gap in support and stimulate the transition from training to independence among promising cancer investigators. -Investigator Initiated Research: Grants of up to $25,000 per year for three to four years, to explore new ideas and approaches with significant potential to lead to reductions in breast cancer mortality and/or incidence within the decade. -Post Baccalaureate in Disparities Research: Grants up to $135,000 per year over three years, to support training programs for graduate students in the area of breast cancer disparities in breast cancer outcomes across population groups. The grant slate approved for funding through the above-referenced opportunities is comprised of the following: -The majority of the grants will address important questions related to the biology of breast cancer (46%), including understanding chromosomal changes in the initiation of breast cancer, the role of oncogenes and tumor suppressor genes. -Of the biology-based projects, the major focus of these projects is on breast cancer progression and metastasis. -Grants addressing methods for treatment, with significant focus on discovery and development of systemic therapies, are the second highest concentration of grants (27%) . -Grants addressing early detection, diagnosis and prognosis, with significant focus on biomarker discovery, validation, and application comprise 12% of the grant slate. -Grants addressing the exogenous and endogenous causes of breast cancer (etiology) comprise 5% of the grant slate. -Grants investigating issues related to cancer control, survivorship, and outcomes comprise 6% of the grant slate. -Grants focusing on strategies to prevent breast cancer, such as through the use of vaccines and personal behavior interventions, comprise 4% of the grant slate. Below are specific examples of promising research and training grants committed in fiscal year 2012: -A $4 million Promise Grant to Drs. Matthew Ellis and Pascal Meier, of Washington University in St. Louis to better identify which women with ER-positive disease are at highest risk for late recurrence, and then targeting those at high risk with more effective therapies. The team will study changes in the DNA structure of breast cancer cells versus normal cells, and develop better ways to kill the breast cancer cells before they spread. -A $4 million Promise Grant to Drs. Bert O'Malley and Kent Osborne, at Baylor College of Medicine in Houston, to identify women who will not benefit from the most commonly used therapies today - tamoxifen or aromatase inhibitors - and develop new therapies for women with this form of the disease. This study may lead to the first new drug in years to prevent recurrence in women with ER-positive breast cancer. -A $250,000 Scholar Grant to Dr. Anne McTiernan, of the Fred Hutchinson Cancer Research Center in Seattle, to investigate the incremental effect of vitamin D supplementation in overweight and obese postmenopausal women with low blood vitamin D levels on response to a weight loss (diet + exercise) intervention. The proposed research will provide important information about vitamin D insufficiency and weight, two potentially modifiable risk factors for breast cancer. -A $888,000 Investigator-Initiated Research Grant to Dr. Michelle Cote, of Wayne State University, to study markers to identify African American women at the highest risk for developing breast cancer. -A $250,000 Scholar Grant to Dr. Mary-Claire King, of the University of Washington in Seattle, to identify new genes that will better identify women at risk for inherited breast cancer -A $450,000 Career Catalyst Research Grant to Dr. Keith Bahjat, of Providence Portland Medical Center, to develop a vaccine against a gene commonly seen in HER-2 positive breast cancer, which represents 15 to 20 percent of breast cancer cases. The hope is to combine vaccine therapy with treatment drugs to prevent recurrence. -A $450,000 Career Catalyst Research Grant to Dr. Elisabeth Battinelli, of Brigham and Woman's Hospital in Boston, to understand why some blood-clot medicines like heparin are leading to prolonged survival and less metastatic disease in breast cancer patients. Komen also supported dozens of partnerships and special projects to advance research and our understanding of breast cancer around the world. These grants respond to unique opportunities, leverage the work of different organizations, and address critical challenges and cross-cutting issues in research, clinical practice, and public health. Examples of special projects committed in fiscal year 2012 include the following: RxPONDER: Rx for Positive Node, Endocrine Responsive Breast Cancer (SWOG-S1007) - $250,000 to provide funding for the cost of Oncotype DX testing for women participating in the Phase III clinical trial called RxPONDER (Rx for Positive Node, Endocrine Responsive Breast Cancer) who are uninsured or whose insurance companies will not reimburse for the test. The RxPONDER trial will help determine whether multi-gene tumor assays (Oncotype DX) can be used to identify women with node-positive breast cancer who could forego chemotherapy. Institute of Medicine (IOM) - Improving the Quality of Cancer Care: Addressing the Challenges of an Aging Population - $50,000 to support an IOM consensus study to examine issues in the quality of cancer care with an emphasis on shifting demographics in the US that will rapidly accelerate the number of new cancer diagnoses at a time when oncology workforce shortages are predicted. The study considers quality of care from the perspectives of key stakeholders, including patients, health care providers, and payers; examines opportunities for and challenges to the delivery of high quality cancer care to an aging population, including the impact of health care reform and disparities of care; and formulates recommendations for improvements. |
| Program Service Accomplishments (Contd) | B - Education | Komen is a trusted source of breast health and breast cancer information for people all over the world and is instrumental in connecting people with the resources they need in their fight against breast cancer. Our award-winning website, www.komen.org, provides safe, accurate, comprehensive, and unbiased information about breast cancer based upon scientific evidence, as well as information about our research programs, community programs, volunteer opportunities, and events. The "Understanding Breast Cancer" section of the website, co-developed with Harvard Medical School faculty and Dana-Farber/Brigham and Women's Cancer Center staff, received over 2.5 million visits during fiscal year 2012. Komen also produced evidence-based, easy-to-read educational materials. Komen and its Affiliates distributed nearly 6 million educational materials in fiscal year 2012. Examples of Komen educational materials include the following: - Breast Self-Awareness cards in 19 languages for 22 specific audiences - General breast health awareness and breast cancer specific brochures and fact sheets - Booklets with support information for survivors and co-survivors Komen's trained and caring breast care helpline staff (1-877 GO KOMEN) provide answers to questions, local resources and moral support. Last fiscal year, the Susan G. Komen for the Cure breast cancer helpline responded to over 13,000 calls and 1,100 emails. While older African American women are less likely to be diagnosed with breast cancer than Caucasian women, they are more likely to die from the disease at every age. Susan G. Komen for the Cure's Circle of Promise program engages African American women, and black women around the world, in the fight against breast cancer. At the end of fiscal year 2012, a total of 100,000 ambassadors had been recruited to do the following: - Mobilize the community to ensure that women everywhere have access to the care they need; - Empower women to make a promise to reclaim their lives, their health and to be strong advocates in their communities; and - Dispel myths in the African American community that prevent women from getting early treatment for breast cancer. I AM THE CURE is an educational program that teaches simple, action-oriented, breast health information to participants in the Susan G. Komen Race for the Cure series. Last year, nearly 1.7 million people participated in a Race for the Cure event. A formal evaluation showed that 82% of participants recalled the message that early detection is key to survival. The mobile community education and outreach tour, Komen On the Go, shares important information about breast cancer with all generations across the country. From inner cities to community festivals, public universities to neighborhood centers, Komen On The Go signature bright pink vehicles are teaching Americans everywhere to take charge of their breast health and empowering participants to share information with friends and join the breast cancer movement. During fiscal year 2012, Komen on the Go was on exhibit for more than 87 days in 30 communities across the United States, educating more than 62,000 people with important breast health information and reaching nearly one million people through social media engagement. Cancer kills more people, worldwide, than TB, HIV/AIDS and malaria combined. Komen is waging the global fight against breast cancer by building and strengthening grassroots programs through networking, training, capacity building and financial support. In fiscal year 2012, 292 breast cancer advocates in six countries (Brazil, Costa Rica, Mexico, Panama, Romania, and Ukraine) were trained on the Community Educators program and Course for the Cure curricula. The Community Educators program is a theory-based trainer curriculum targeted for education program planners and Course for the Cure is a series of capacity building modules based on Komen's best practices and experience aimed at helping local non-government organizations increase their reach and impact. In partnership with the Caterpillar Foundation, grant programs in Brazil, Panama, and Mexico reached an estimated 4.6 million people through awareness campaigns and trained 2,715 community health workers, medical providers and Caterpillar employees on breast self awareness and breast cancer. Also, these grants provided for the distribution of 152,774 educational materials, 144 clinical breast exams, 745 mammogram referrals, and 89 mammograms. Komen also awarded grants for outreach programs in Bosnia and Herzegovina, Brazil, China, Egypt, Ghana, Hebron, Hungary, Israel, Jordan, Montenegro, Peru, Romania, Russia, South Africa, Switzerland, Taiwan, Ukraine, Zambia and for conferences in Lithuania and Spain. |
| Program Service Accomplishments (Contd) | C - Screening | Getting regular screening tests is the best way for women to lower their risk of dying from breast cancer. Screening tests can find breast cancer early, when it's most treatable. Komen supports free and low-cost mammogram programs in communities for women without health insurance or those with high co-pays and deductibles that make getting a mammogram too costly. In 2012, Komen awarded $4 million in new community grants to reach low-income, minority and uninsured women who fall through the healthcare gaps in the Washington, D.C. Metro area, where death rates from breast cancer continue to rank above national averages. The new Komen grants bring to 30 the number of Komen-funded programs in the D.C. area that strive to improve access and services to women facing breast cancer, representing a total in active grant funding of $11 million during 2011 and 2012. The five largest grants ($2,500,000 in 2012 and $1,917,000 in 2011) in the Washington, D.C. Metro area focus on addressing barriers to care caused by the area's overly fragmented heath care system. They encourage partnerships between providers in the region that establish a framework to ensure that patients can be easily and efficiently referred and "navigated" from screening all the way through to survivorship-with particular emphasis on removing obstacles to transportation and work obligations, wait times, and financial assistance. Fourteen grants ($2,779,981-eleven of which are continued from 2011; three of which are new in 2012) focus on patient education, including targeted breast health awareness outreach in a culturally sensitive manner that develops a better understanding of the importance of screening, the effectiveness of modern treatments and survivorship. Two grants ($400,000-programs continued from 2011) focus on provider education, helping doctors and other breast health providers develop a better understanding of the myths, fears and unique needs of the different cultural populations of the women they serve. The programs educate providers about updated screening guidelines, and how best to help refer patients through the complex web of screening, diagnosis, treatment and follow-up care. Two grants ($626,476 total in 2012 ) were awarded as part of the National Capital Area Continuum of Care Special Initiative. The purpose of this special funding initiative is to decrease the time it takes for a person to move from early detection and diagnosis to treatment and recovery; to increase mammography rates; change attitudes, knowledge and beliefs, and improve quality of life for patients going through treatment. Through Komen's National Vulnerable Populations Grants Program, Komen funds large-scale community grants that seek to improve quality of care, care coordination, and address unique barriers to breast care for disparate populations. Since the initiation of these grants in 2008, Komen has invested over $7 million in programs that aim to eliminate disparities in breast cancer mortality. The following are some examples of the projects funded in fiscal year 2012 through Komen's National Vulnerable Population Grants Program: Komen funded an initiative with four Consulates of Mexico in the United States to integrate breast health materials and education into their Ventanillas de Salud (Window of Health) program (VDS program). The initiative involves a new pilot program that aims to eliminate disparities in breast cancer mortality among Mexican, Mexican-American and Hispanic women in the U.S. As a part of this new initiative, Komen awarded a total of $200,000 to four separate fiscal agencies that partner with Mexican Consulates to operate each local VDS program. The initial phase of the initiative will help build organizational capacity in four select markets to address key breast health barriers that are unique to Latino populations. The initiative not only integrates breast health materials into the VDS program, but also increases the program's reach into the community. Komen also awarded a $500,000 grant to the American Association on Health and Disability to fund Project Accessibility USA: Removing Barriers for Women with Disabilities. The goal of the project is to work towards reducing breast cancer health disparities in women with disabilities by improving accessibility of screening sites; providing site specific recommendations to providers on strategies to ensure accessibility for women with disabilities; developing a web-based Resource Learning Center; and developing educational training modules on disability culture and sensitivity for healthcare professionals. Komen awarded $225,000 to the National Cancer Institute to sponsor the California Health Interview Survey (CHIS) breast cancer control data collection. CHIS is the largest and most comprehensive state health survey in the United States. CHIS provides the only robust breast cancer screening estimates for Asian Americans nationalities in the U.S. As no Asian women were interviewed about mammography in an Asian language in 2011, funding from Komen will allow Asian respondents to be interviewed during 2012, thereby capturing critical information to inform future research and programs to improve breast health for Asian Americans. Komen awarded $134,552 to Eastern Michigan University Foundation to fund the Healthy Asians American Project. This project will increase breast health awareness and access through trained lay health advisors in underserved areas throughout China and Taiwan. D - Treatment Countless numbers of patients delay or forgo breast cancer treatment each year, and as a result, these women are less likely to survive. For this reason, Komen supports programs that connect people with local resources, psychosocial support, and provide critical financial assistance. In 2012, Komen awarded a $500,000 grant to CancerCare to support the Linking A.R.M.S.TM (Assistance & Resources Made Simple) program. Linking A.R.M.S.TM is a program dedicated to providing financial assistance, education and support services to low-income, under- or uninsured breast cancer survivors. Funding for Linking A.R.M.S.TM provides direct financial assistance to approximately 1,336 breast cancer survivors for treatment-related expenses including pain and anti-nausea medication, lymphedema care, oral chemotherapy, durable medical equipment, childcare, and transportation to and from treatment. CancerCare also provides counseling and other support services that enable breast cancer patients to make informed treatment decisions, cope with the emotional effects of the disease, and experience an improved quality of life. In addition, Komen awarded a $1,500,000 grant to the Patient Advocate Foundation, a national non-profit organization that handles medical debt crisis management, for its Co-Pay Relief (CPR) program. The CPR program was launched in April 2004, providing direct financial assistance for pharmaceutical co-payments to patients with breast cancer, lung cancer and prostate cancer. Komen's funding, along with that of other key partners, will touch more than 10,000 breast cancer patients served through the program over the next two years. All told, Komen and its Affiliates have committed more than $1.8 billion to community programs since 1982, and in fiscal year 2012 partnered with almost 2,000 organizations to provide education, screening, treatment support and psychosocial programs. For more information about any of the accomplishments described here or to learn more about Susan G. Komen for the Cure, visit www.komen.org or call 1-877 GO KOMEN (1-877-465-6636). |
| Description of Relationships | Form 990, Part VI, Question 2 | Eric Brinker, Board Member, is the son of Nancy G. Brinker, CEO and Board member. Describe the Process used by Management &/or Governing Body to Review 990 Form 990, Part VI, Question 11b Management prepares the materials for the Form 990, with the assistance and review by external accountants. Senior levels of management review and comment on the final draft of the Form 990 for presentation to the audit committee of the board of directors. The audit committee of the Board of the Directors reviews and approves the Form 990 prior to being filed. Thereafter, each member of the Board of Directors receives an electronic copy of the Form 990 via email prior to the form being filed. Description of Process to Monitor Transactions for Conflicts of Interest Form 990, Part VI, Question 12c The organization produces an annual survey requiring all employees, board members, committee members and advisory boards to inform on conflicts. Any conflicts are then reviewed by management and the audit committee and appropriate measures are taken. In addition, those same people have the obligation to update the conflict of interest statements during the year. Offices & Positions for Which Process was Used, & Year Process was Begun Form 990, Part VI, Question 15a and 15b The Compensation Committee of the Board of Directors assists the Board of Susan G. Komen for the Cure in overseeing compensation policies and practices. Responsibilities include oversight of the compensation of the President/ Chief Executive Officer, the range of compensation levels for the organization's other officers, disqualified persons, and other employees, granting the CEO authority to determine actual compensation levels within an approved range, and incentive/bonus compensation programs. The current policy was adopted in 2010. A formal Compensation Policy governs pay practices. Periodically, all positions in the organization are reviewed against external market data, engaging independent experts to conduct the benchmarking process. Compensation is then based upon comparable market rates of pay with consideration for internal equity and the financial position of the organization. For the CEO and officers of the organization, external benchmarking was conducted again this fiscal year to ensure market alignment. Salary increases, promotions or other forms of compensation are provided without regard to race, color, religion, gender, national origin, disability, veteran status or sexual orientation. Avail of Gov Docs, Conflict of Interest Policy, & Fin Stmts to Gen Public Form 990, Part VI, Question 19 The Organization's financial statements, conflict of interest policy and the 990 are publicly available on our website. The Articles of Incorporation are available from the Texas Secretary of State and other governing documents are made available as required by state law. Form 1023 is not online but available to the public upon request. ADDITIONAL DETAIL ON RACE PRODUCTION EXPENSES INCLUDED ON OTHER EXP LINE Form 990, Part IX, Line 24 THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. PURCHASES ALL T-SHIRTS FOR THE 133 RACES HELD BY THE KOMEN AFFILIATES DURING THE YEAR. Reconciliation of Net Assets Part XI, Line 5 Unrealized losses on investments = ($3,580,874) In Kind services Revenues = $13,250,636 In Kind services expenses = ($14,060,197) Rescinded Grants = $1,734,535 ----------- Total ($2,655,900) |
| Software ID: | |
| Software Version: |